🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

16+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 16 recruiting trials for “glycogen-storage-disease-due-to-aldolase-a-deficiency

NARecruitingNCT07478172

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

🏥 University of Missouri-Columbia📍 1 site📅 Started Mar 2026View details ↗
Phase 1, PHASE2RecruitingNCT07282847

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

🏥 AskBio Inc📍 10 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07123155

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

🏥 Shionogi📍 28 sites📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT06666413

China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

👨‍⚕️ Trial Transparency email recommended (Toll free for US & Canada)📍 1 site📅 Started May 2025View details ↗
RecruitingNCT06795152

Rare Glycogen Storage Diseases Natural History Study

👨‍⚕️ Priya Kishnani, M.D., Duke📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06391736

Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug

👨‍⚕️ Guang Yang, Chinese PLA General Hospital📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06121011

A Global Prospective Observational Registry of Patients With Pompe Disease

🏥 Amicus Therapeutics📍 41 sites📅 Started Feb 2024View details ↗
RecruitingNCT06214507

Danon Disease Natural History Study

🏥 Rocket Pharmaceuticals Inc.📍 13 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06092034

A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

👨‍⚕️ Joseph Rossano, MD, Children's Hospital of Philadelphia📍 6 sites📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT04808505

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

🏥 Amicus Therapeutics📍 14 sites📅 Started Jul 2023View details ↗
RecruitingNCT03564561

Natural History of Pompe Disease

👨‍⚕️ Helge Amthor, MD, PhD, Hôpital Raymond Poincaré📍 1 site📅 Started Jun 2019View details ↗
RecruitingNCT04639336

Cognitive and Neurological Pathologies in Pompe Disease

👨‍⚕️ Priya Kishnani, MD, Duke University📍 1 site📅 Started Aug 2016View details ↗
NARecruitingNCT07336394

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

👨‍⚕️ Minjie Lu MD, PhD📍 1 site📅 Started Jan 2010View details ↗
RecruitingNCT01665326

Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

👨‍⚕️ Priya S Kishnani, MD, Duke University📍 1 site📅 Started Sep 2009View details ↗
RecruitingNCT02399748

A Long-term Study for the Outcome of Pompe Disease

👨‍⚕️ Yin-Hsiu Chien, National Taiwan University Hospital📍 1 site📅 Started Apr 2007View details ↗
NARecruitingNCT00231400

Pompe Disease Registry Protocol

👨‍⚕️ Study Director, Genzyme, a Sanofi Company📍 20 sites📅 Started Sep 2004View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →